Kiniksa Pharmaceuticals International, plc (KNSA) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$677.6M

Net Income/Loss (FY2025)

$59.0M

Total Assets (FY2025)

$763.6M

Total Equity (FY2025)

$567.6M

Cash Flows from Operating Activities (FY2025)

$138.0M

Source: Kiniksa Pharmaceuticals International, plc 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.